|
Ranking PR | ≥ weak (%) | ≥ mod (%) | Strong (%) |
|
Tubular carcinoma of the breast | 82.6 | 73.9 | 65.2 |
Granulosa cell tumor of the ovary | 81.1 | 51.4 | 21.6 |
Mucinous carcinoma of the breast | 76.5 | 68.6 | 60.8 |
Phyllodes tumor of the breast | 73.0 | 73.0 | 54.1 |
Sertoli Leydig cell tumor of the ovary | 66.7 | 0.0 | 0.0 |
Endometrioid endometrial carcinoma | 66.5 | 44.7 | 31.0 |
Endometrioid carcinoma of the ovary | 62.0 | 43.5 | 29.3 |
Invasive breast carcinoma of no special type | 57.1 | 46.5 | 35.8 |
Lobular carcinoma of the breast | 57.0 | 47.0 | 37.4 |
Pancreas, neuroendocrine tumor (NET) | 54.3 | 37.2 | 27.7 |
Leydig cell tumor of the ovary | 50.0 | 0.0 | 0.0 |
Leydig cell tumor of the testis | 36.7 | 3.3 | 0.0 |
Pancreas, neuroendocrine carcinoma (NEC) | 35.7 | 28.6 | 14.3 |
Carcinosarcoma of the ovary | 34.1 | 11.4 | 4.5 |
Serous carcinoma of the ovary | 32.1 | 10.0 | 5.8 |
Endometrial serous carcinoma | 20.6 | 5.9 | 2.9 |
Medullary thyroid carcinoma | 20.4 | 3.7 | 1.9 |
Endometrial carcinoma, high grade, G3 | 16.7 | 8.3 | 8.3 |
Small cell neuroendocrine carcinoma of the prostate | 16.7 | 0.0 | 0.0 |
Small cell carcinoma of the lung | 12.5 | 6.3 | 0.0 |
Angiomyolipoma | 12.5 | 3.4 | 3.4 |
Carcinosarcoma of the uterus | 12.2 | 7.3 | 7.3 |
Medullary carcinoma of the breast | 12.1 | 9.1 | 6.1 |
Adrenal cortical carcinoma | 11.5 | 0.0 | 0.0 |
Follicular thyroid carcinoma | 11.3 | 6.0 | 2.6 |
Clear cell carcinoma of the ovary | 11.1 | 4.4 | 2.2 |
Leiomyosarcoma | 10.8 | 8.1 | 8.1 |
Papillary thyroid carcinoma | 10.6 | 1.6 | 0.5 |
Adenocarcinoma of the cervix | 9.5 | 4.8 | 0.0 |
Adenoma of the thyroid gland | 7.1 | 2.7 | 0.0 |
Oncocytoma | 6.9 | 0.4 | 0.0 |
Myoepithelial carcinoma of the salivary gland | 5.9 | 5.9 | 0.0 |
Appendix, neuroendocrine tumor (NET) | 5.9 | 5.9 | 0.0 |
Mucinous carcinoma of the ovary | 5.2 | 5.2 | 5.2 |
Brenner tumor | 5.0 | 5.0 | 5.0 |
Teratoma | 4.9 | 4.9 | 4.9 |
Neurofibroma | 4.8 | 0.0 | 0.0 |
Chromophobe renal cell carcinoma | 4.6 | 1.3 | 1.3 |
Adrenal cortical adenoma | 4.5 | 2.3 | 2.3 |
Small cell neuroendocrine carcinoma of the bladder | 4.3 | 0.0 | 0.0 |
Clear cell (tubulo) papillary renal cell carcinoma | 4.2 | 4.2 | 0.0 |
Adenocarcinoma NOS of the salivary gland | 2.5 | 2.5 | 1.2 |
Anaplastic thyroid carcinoma | 2.3 | 0.0 | 0.0 |
Ductal adenocarcinoma of the pancreas | 2.2 | 1.2 | 0.6 |
Urothelial carcinoma of the kidney pelvis | 1.6 | 0.0 | 0.0 |
Sarcoma, not otherwise specified (NOS) | 1.4 | 1.4 | 1.4 |
Squamous cell carcinoma of the cervix | 0.8 | 0.0 | 0.0 |
Adenocarcinoma of the prostate (recurrence) | 0.4 | 0.0 | 0.0 |
Urothelial carcinoma, pT2-4 G3 | 0.3 | 0.3 | 0.3 |
Mucoepidermoid carcinoma of the salivary gland | 0.3 | 0.3 | 0.0 |
Papillary renal cell carcinoma | 0.3 | 0.0 | 0.0 |
Adenocarcinoma of the colon | 0.1 | 0.0 | 0.0 |
Clear cell renal cell carcinoma | 0.1 | 0.0 | 0.0 |
|